Home / Share Price Target / Suven
Suven Life Sciences Share Price Target 2024, 2025, 2026 to 2039 With Charts
Suven Life Sciences Limited | |||
 | Symbol: SUVEN | ||
| Price: ₹120.97 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Suven Life Sciences Brief Company Overview
- 1.1: Suven Life Sciences Limited: Leading the Way in Neurodegenerative Therapies
- 1.1.1: Commitment to Innovation
- 1.2: Suven Life Sciences Financial Performance
- 1.2.1: Is Suven Life Sciences A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Suven Life Sciences Share Price Target For 2024
- 2.1.1: Suven Life Sciences Share Price Target Table For 2024
- 2.1.2: Summary: Suven Life Sciences Share Price Prediction For 2024
- 2.2: Suven Life Sciences Share Price Target For 2025
- 2.2.1: Suven Life Sciences Share Price Target Table For 2025
- 2.2.2: Summary: Suven Life Sciences Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Suven Life Sciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Suven Life Sciences Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Suven Life Sciences Past Performance
Suven Life Sciences Brief Company Overview
Suven Life Sciences Limited: Leading the Way in Neurodegenerative Therapies
Suven Life Sciences Limited, a renowned clinical-stage biopharmaceutical company, has dedicated itself to developing cutting-edge therapeutics for neurodegenerative disorders.
Established in 1989 and headquartered in Hyderabad, India, Suven Life Sciences has a global presence, focusing on drug discovery and development of novel chemical entities (NCEs) for central nervous system therapies.
Commitment to Innovation
Suven Life Sciences is renowned for its extensive product range, including:
- Masupirdine: Treatment of Alzheimer's disease and neuropsychiatric symptoms
- Samelisant: Treatment of sleep and cognitive disorders
- Ropanicant: Treatment of depressive disorders
- Usmarapride: Treatment of cognitive disorders
- Other promising NCEs in various stages of development
Suven Life Sciences' unwavering commitment to research and development has positioned them as a leader in the neurodegenerative field.
Suven Life Sciences Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,182.92 Crore | Market valuation of Suven Life Sciences's shares. |
| Revenue (TTM) | 11.69 Crore | Total revenue generated by Suven Life Sciences over the past twelve months. |
| Net Income (TTM) | -105.07 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -1333.07% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 100% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -10.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -8.66% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 0.26 | Company's total debt divided by total shareholder equity. |
| Total Debt | 70.97 Lakh | Sum of Suven Life Sciences's current & long-term financial obligations. |
| Total Cash | 242.11 Crore | Total amount of liquid funds available to Suven Life Sciences. |
| Beta | 1.51 | Beta is greater than 1 indicating that the Suven Life Sciences's price is more volatile than the market. |
Is Suven Life Sciences A Good Buy For Long Term?
Suven Life Sciences' recent financial performance has been mixed. Its net profit has declined in the last 12 months, and it has a relatively low profit margin. However, the company has strong cash reserves and its revenue has increased significantly over the past 3 years. Overall, the company's long-term prospects appear to be uncertain and it is difficult to recommend it as a buy or a sell at this time.
To predict the Suven Life Sciences's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Suven Life Sciences Share Price Target For 2024
The line chart displays the monthly closing prices of Suven Life Sciences with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Suven Life Sciences shares in 2024, see the table below.
Suven Life Sciences Share Price Target Table For 2024
| Suven Life Sciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 124.49 (+2.9%) | Technical Indicator: MA150 |
| 2024 Target 2 | 123.20 (+1.84%) | Price Action: 28 Oct 2024 High |
| 2024 Target 1 | 121.81 (+0.69%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 120.97 | Suven Life Sciences's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 120.71 (-0.22%) | Price Action: Chart |
| Stop Loss 2 | 119.00 (-1.63%) | Fibonacci Retracement Extended 28.2% |
| Stop Loss 3 | 117.80 (-2.63%) | Fibonacci Retracement Extended 61.8% |
Summary: Suven Life Sciences Share Price Prediction For 2024
In summary, Suven Life Sciences has surged by ₹40.22, achieving a notable +49.81% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Suven Life Sciences for 2024 predicts an additional rise of 0.69% to 2.9% by the end of 2024 with three potential targets T1: 121.81, T2: 123.20, T3: 124.49. Stop Loss at SL1: 120.71, SL2: 119.00, SL3: 117.80.
Suven Life Sciences has a 52-week high of ₹169.30, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹74.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Suven Life Sciences.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Suven Life Sciences Share Price Target For 2025
The line chart displays the monthly closing prices of Suven Life Sciences with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Suven Life Sciences shares in 2025, see the table below.
Suven Life Sciences Share Price Target Table For 2025
| Suven Life Sciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 171.87 (+42.07%) | Price Action: Chart |
| 2025 Target 2 | 168.67 (+39.43%) | Custom Fibonacci Extension Lvl 64.9% |
| 2025 Target 1 | 165.35 (+36.68%) | Fibonacci Extension Level 123.6% |
| Current Price | 120.97 | Suven Life Sciences's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 109.75 (-9.28%) | Price Action: Apr 2024 Low |
| Stop Loss 2 | 107.95 (-10.77%) | Price Action: Jun 2024 High |
| Stop Loss 3 | 106.71 (-11.79%) | Price Action: Apr 2021 High |
Summary: Suven Life Sciences Share Price Prediction For 2025
In summary, Suven Life Sciences has surged by ₹40.22, achieving a notable +49.81% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Suven Life Sciences for 2025 predicts an additional rise of 36.68% to 42.07% by the end of 2025 with three potential targets T1: 165.35, T2: 168.67, T3: 171.87. Stop Loss at SL1: 109.75, SL2: 107.95, SL3: 106.71.
Suven Life Sciences has a All-Time high of ₹338.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹74.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Suven Life Sciences, we have created a specific page for that check here: Suven Life Sciences Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Suven Life Sciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Suven Life Sciences share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 16.7% over the next 15 years.
For complete year by year Suven Life Sciences long term share price target from 2024, 2025 to 2039 check the below table.
Suven Life Sciences Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Suven Life Sciences Target | YoY Change % |
|---|---|---|
| 2024 | ₹120.97 | [Current Price] |
| 2024 | ₹159.56 | 31.9% |
| 2025 | ₹135.87 | -14.85% |
| 2026 | ₹435.79 | 220.74% |
| 2027 | ₹498.99 | 14.5% |
| 2028 | ₹464.46 | -6.92% |
| 2029 | ₹591.99 | 27.45% |
| 2030 | ₹374.66 | -36.72% |
| 2031 | ₹1,002.5 | 167.57% |
| 2032 | ₹1,013.94 | 1.14% |
| 2033 | ₹861.77 | -15.01% |
| 2034 | ₹1,024.43 | 18.87% |
| 2035 | ₹613.45 | -40.12% |
| 2036 | ₹1,569.2 | 155.79% |
| 2037 | ₹1,528.9 | -2.57% |
| 2038 | ₹1,259.08 | -17.65% |
| 2039 | ₹1,385.9 | 10.07% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Suven Life Sciences Past Performance
- In 1995, Suven Life Sciences opening price was ₹2.81
- As of Tue 19 Nov 2024 the price stands at ₹120.97.
- This represents a Compound Annual Growth Rate (CAGR) of 13.36%.
- In 29 years, an investment of 10,000 would have become ₹4.3 Lakh.
As we wrap up, we hope you like our study on Suven Life Sciences share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Suven Life Sciences Share Price History
- Suven Life Sciences Price Target Tomorrow
- Suven Life Sciences Dividend History
- Suven Life Sciences Bonus History
- Suven Life Sciences Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
